PT  - JOURNAL ARTICLE
AU  - Lu, Tianshi
AU  - Socinski, Mark A
AU  - Reck, Martin
AU  - West, Howard
AU  - Cappuzzo, Federico
AU  - Barlesi, Fabrice
AU  - Jotte, Robert M
AU  - Müller, Sören
AU  - Hamidi, Habib
AU  - Amitai, Assaf
AU  - Koeppen, Hartmut
AU  - Shames, David S
AU  - Ballinger, Marcus
AU  - Qamra, Aditi
AU  - Srivastava, Minu K
AU  - Nabet, Barzin
TI  - 601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC
AID  - 10.1136/jitc-2023-SITC2023.0601
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A684--A684
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A684.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A684.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.